NCT00581165View on ClinicalTrials.gov

Study Evaluating Safety of Etanercept in Treatment of Patients With Moderate to Severe Psoriasiswith Etanercept

PHASE4CompletedINTERVENTIONAL

Enrollment

500

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions

Psoriasis

Interventions

DRUG

Etanercept

recommended dose of enbrel is 25mg administered twice weekly.

All Listed Sponsors

lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00581165 - Study Evaluating Safety of Etanercept in Treatment of Patients With Moderate to Severe Psoriasiswith Etanercept | Biotech Hunter | Biotech Hunter